Group 1 - The company, Guichuang Tongqiao, repurchased 100,000 shares at an average price of HKD 23.20, totaling approximately HKD 2.32 million, with a cumulative repurchase of 4.0145 million shares this year, representing 1.26% of the total share capital [1] - As of the market close on the same day, Guichuang Tongqiao's stock price decreased by 1.18%, closing at HKD 23.38 per share [1] - Stock repurchase is typically a strategy employed by management when they believe the company's stock is undervalued, indicating confidence in future development despite market perceptions [1] Group 2 - Guichuang Tongqiao is an innovative medical device company listed on the Hong Kong Stock Exchange, focusing on the research, production, and sales of neuro and peripheral vascular interventional medical devices [2] - The company invests significantly in technology research and development, holding a series of proprietary technologies, and its product range includes various interventional medical devices such as stents [2] - With the growing demand for interventional treatments in the medical industry, Guichuang Tongqiao faces opportunities for development while also needing to address market competition and technological advancements [2]
归创通桥回购10.00万股股票，共耗资约232.03万港元，本年累计回购401.45万股